Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma

Published:2001-05 Issue:5 Volume:15 Page:832-839
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Niitsu N,Okamoto M,Okabe-Kado J,Takagi T,Yoshida T,Aoki S,Honma Y,Hirano M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402105.pdf

Reference32 articles.

1. Bastion Y, Berger F, Bryon PA, Felman P, Ffrench M, Coiffier B . Follicular lymphoma: assessment of prognostic factors in 127 patients followed for 10 years Ann Oncol 1991 2: (Suppl. 2) 123–134

2. The International Non-Hodgkin's Lymphoma Prognostic Factors Project . A predictive model for aggressive non-Hodgkin's lymphoma: the International NHL Prognostic Factors Project New Engl J Med 1993 329: 987–994

3. Czuczman MS, Grillo-Lopez AJ, White CA, Saleh M, Gordon L, LoBuglio AF, Jonas C, Klippenstein D, Dallaire B, Varns C . Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy J Clin Oncol 1999 17: 268–276

4. Vose JM, Wahl RL, Saleh M, Rohatiner AZ, Knox SJ, Radford JA, Zelenetz AD, Tidmarsh GF, Stagg RJ, Kaminski MS . Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas J Clin Oncol 2000 18: 1316–1323

5. Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Robertson MJ, Blake K, Coral F, Canellos GP, Ritz J, Nadler LM . Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study J Clin Oncol 1993 11: 931–936

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A competitive cell-permeable peptide impairs Nme-1 (NDPK-A) and Prune-1 interaction: therapeutic applications in cancer;Laboratory Investigation;2018-02-15

2. The ‘known-knowns’, and ‘known-unknowns’ of extracellular Nm23-H1/NDPK proteins;Laboratory Investigation;2018-01-16

3. Extracellular NME proteins: a player or a bystander?;Laboratory Investigation;2017-10-16

4. Characteristics of Potential Protein Biomarkers Extracted with 10% TCA from Blood Serum of Non-Hodgkin's Lymphoma and Multiple Myeloma Patients;INT J MOL CELL MED;2017

5. Amplification of 2p as a genomic marker for transformation in lymphoma;Genes, Chromosomes and Cancer;2014-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3